Activity

Filter

Cancel
Date Panel Item Activity
10 actions
Genetic Epilepsy v2.0 AMACR Gene migrated from ENSG00000242110 to ENSG00000242110 (gene set migration)
Genetic Epilepsy v0.1996 AMACR Zornitza Stark Phenotypes for gene: AMACR were changed from ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY MIM#614307 to Alpha-methylacyl-CoA racemase deficiency, MIM# 614307
Genetic Epilepsy v0.1994 AMACR Elena Savva Phenotypes for gene: AMACR were changed from Alpha-methylacyl-CoA racemase deficiency (MIM#614307) to ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY MIM#614307
Genetic Epilepsy v0.1993 AMACR Elena Savva Phenotypes for gene: AMACR were changed from ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY - 614307 to Alpha-methylacyl-CoA racemase deficiency (MIM#614307)
Genetic Epilepsy v0.1992 AMACR Elena Savva Publications for gene: AMACR were set to (PMID:35428665; 21576695; 11060344; 21686617
Genetic Epilepsy v0.1982 AMACR Zornitza Stark Marked gene: AMACR as ready
Genetic Epilepsy v0.1982 AMACR Zornitza Stark Gene: amacr has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1982 AMACR Zornitza Stark Classified gene: AMACR as Green List (high evidence)
Genetic Epilepsy v0.1982 AMACR Zornitza Stark Gene: amacr has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1975 AMACR John Coleman gene: AMACR was added
gene: AMACR was added to Genetic Epilepsy. Sources: Literature,Expert Review
Mode of inheritance for gene: AMACR was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: AMACR were set to (PMID:35428665; 21576695; 11060344; 21686617
Phenotypes for gene: AMACR were set to ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY - 614307
Penetrance for gene: AMACR were set to unknown
Review for gene: AMACR was set to GREEN
Added comment: Autosomal recessive affecting AMACR enzyme which is active in the mitochondrial & peroxisome. AMACR deficiency and Congenital Bile Acid Synthesis Defect 4 are distinctive phenotypes. Epilepsy a feature of AMACR deficiency on OMIM. AMACR deficiency reported in adults with later onset tonic clonic seizures in a 58 year old male, also had cerebellar features. Second case of female in her 70s with lacosamide responsive seizures and other neurological manifestations. Case series (Thompson et al 2009) - 44 year old male seizures onset at age 18, 52 year old female seizure onset 50s, and 57 y/o female tonic clonic seizures onset at age 13. Variable condition.
Sources: Literature, Expert Review